Literature DB >> 20491830

Hormographiella aspergillata: an emerging mould in acute leukaemia patients?

A Conen1, M Weisser, D Hohler, R Frei, M Stern.   

Abstract

We describe three invasive mould infections due to Hormographiella aspergillata occurring within 1 year in patients undergoing treatment for acute leukaemia. All patients presented with pulmonary infiltrates; one patient additionally had cerebral and ocular involvement. Diagnostic procedures included bronchoalveolar lavage in all, and video-assisted thoracoscopic surgery in two patients. Susceptibility testing was performed by E-test and detected low minimal inhibitory concentrations for voriconazole and amphotericin B. All patients received systemic antifungal therapy; however, all of them died. Despite this cluster of three cases of an unusual mould infection, no hospital source was detected.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20491830     DOI: 10.1111/j.1469-0691.2010.03266.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

Review 1.  Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.

Authors:  Cendrine Godet; Estelle Cateau; Blandine Rammaert; Marine Grosset; Gwenaël Le Moal; Guillaume Béraud; Jean Philippe Martellosio; Xavier Iriart; Jacques Cadranel; France Roblot
Journal:  Mycopathologia       Date:  2017-01-31       Impact factor: 2.574

2.  Excavated pneumonia: an unusual suspect.

Authors:  Audrey Bellesoeur; Ludivine Chalumeau-Lemoine; François Blot
Journal:  Intensive Care Med       Date:  2013-04-10       Impact factor: 17.440

3.  Filamentous Basidiomycetes in the Clinical Laboratory.

Authors:  Mary E Brandt
Journal:  Curr Fungal Infect Rep       Date:  2013-07-13

4.  Clinical significance and molecular characterization of nonsporulating molds isolated from the respiratory tracts of bronchopulmonary mycosis patients with special reference to basidiomycetes.

Authors:  Pradeep Kumar Singh; Shallu Kathuria; Kshitij Agarwal; Shailendra Nath Gaur; Jacques F Meis; Anuradha Chowdhary
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

5.  Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin.

Authors:  Felipe Suarez; Gaelle Olivier; Dea Garcia-Hermoso; Edouard Randriamalala; David Ghez; Julie Bruneau; Catherine Kauffmann-Lacroix; Marie-Elisabeth Bougnoux; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

6.  Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract.

Authors:  Anuradha Chowdhary; Kshitij Agarwal; Shallu Kathuria; Pradeep Kumar Singh; P Roy; S N Gaur; G S de Hoog; Jacques F Meis
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

7.  Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors?

Authors:  B Babouee Flury; M Weisser; S Savič Prince; L Bubendorf; M Battegay; R Frei; D Goldenberger
Journal:  BMC Infect Dis       Date:  2014-12-18       Impact factor: 3.090

8.  First description of a local Coprinopsis cinerea skin and soft tissue infection.

Authors:  C Correa-Martinez; A Brentrup; K Hess; K Becker; A H Groll; F Schaumburg
Journal:  New Microbes New Infect       Date:  2017-12-05

9.  Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients.

Authors:  Jörg Janne Vehreschild; Philipp Koehler; Frédéric Lamoth; Juergen Prattes; Christina Rieger; Bart J A Rijnders; Daniel Teschner
Journal:  Med Mycol       Date:  2021-01-04       Impact factor: 4.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.